Dänemark - Dänisch - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - alfa-tocopherol, all-rac-, ascorbinsyre, biotin, cholecalciferol, cocarboxylasetetrahydrat, cyanocobalamin, dexpanthenol, folsyre, nicotinamid, pyridoxinhydrochlorid, retinolpalmitat, riboflavin - pulver til injektions-/infusionsvæske, opløsning

Dänemark - Dänisch - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - glucosemonohydrat, kaliumchlorid, natriumchlorid - infusionsvæske - 1,492+2,338+55 mg/ml

Dänemark - Dänisch - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - glucosemonohydrat, natriumchlorid - infusionsvæske, opløsning - 4,5 mg/ml + 25 mg/ml

Dänemark - Dänisch - Lægemiddelstyrelsen (Danish Medicines Agency)

ennogen healthcare (europe) ltd - theophyllin - depottabletter - 200 mg

Europäische Union - Dänisch - EMA (European Medicines Agency)

ceva santé animale - torasemide - high-ceiling diuretics, sulfonamider, almindelig - hunde - til behandling af kliniske symptomer, der er relateret til kongestiv hjerteinsufficiens, i hunde, herunder lungeødem.

Europäische Union - Dänisch - EMA (European Medicines Agency)

advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - stråling skader - detoxifying agents for antineoplastic treatment - lysakare er indiceret til reduktion af nyre-stråling i løbet af peptid-receptor radionuklid terapi (prrt) med lutetium (177lu) oxodotreotide i voksne.

Europäische Union - Dänisch - EMA (European Medicines Agency)

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastiske midler - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Europäische Union - Dänisch - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - irbesartan, hydrochlorothiazid - forhøjet blodtryk - agenter, der virker på renin-angiotensinsystemet - behandling af essentiel hypertension. dette fastdosis kombination er indiceret hos voksne patienter, hvis blodtryk ikke er tilstrækkeligt kontrolleret på irbesartan eller hydrochlorthiazid alene (se afsnit 5.

Dänemark - Dänisch - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm healthcare a/s - furosemid - depotkapsler, hårde - 60 mg

Dänemark - Dänisch - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm healthcare a/s - furosemid - tabletter - 40 mg